98 related articles for article (PubMed ID: 21060274)
1. Full macular translocation for choroidal neovascularization in the era of intravitreal pharmacological therapy.
Haverbeke GM; Claes C
Retina; 2010; 30(10):1739-43. PubMed ID: 21060274
[No Abstract] [Full Text] [Related]
2. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration.
Mruthyunjaya P; Stinnett SS; Toth CA
Ophthalmology; 2004 Sep; 111(9):1715-24. PubMed ID: 15350328
[TBL] [Abstract][Full Text] [Related]
3. Comparing ranibizumab with bevacizumab.
Biswas P; Sengupta S; Choudhary R; Home S; Paul A; Sinha S
Ophthalmology; 2011 Mar; 118(3):600-600.e2. PubMed ID: 21376243
[No Abstract] [Full Text] [Related]
4. Macular functional changes evaluated with MP-1 microperimetry after intravitreal bevacizumab for subfoveal myopic choroidal neovascularization: one-year results.
Scupola A; Tiberti AC; Sasso P; Savastano MC; Mastrocola A; Marangoni D; Minnella AM; Falsini B; Balestrazzi E
Retina; 2010 May; 30(5):739-47. PubMed ID: 20038860
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab for parapapillary choroidal neovascularization due to exudative age-related macular degeneration.
Jonas JB; Tao Y; Rensch F
Acta Ophthalmol; 2011 Feb; 89(1):e105-7. PubMed ID: 20064119
[No Abstract] [Full Text] [Related]
6. Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration.
Guthoff R; Guthoff T; Meigen T; Goebel W
Retina; 2011 Jan; 31(1):36-40. PubMed ID: 20921929
[TBL] [Abstract][Full Text] [Related]
7. [Results of limited macular translocation in subfoveal choroidal neovascularization in age-related macular degeneration].
Pawlak D; Glacet-Bernard A; Papp M; Coscas G; Soubrane G
J Fr Ophtalmol; 2004 Nov; 27(9 Pt 2):3S31-7. PubMed ID: 15602405
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration: a 12-month follow-up study.
Costagliola C; Romano M; Corte MD; Perrotta R; Menzione M; Rinaldi M; Semeraro F; Parmeggiani F
Retina; 2009 Oct; 29(9):1227-34. PubMed ID: 19934817
[TBL] [Abstract][Full Text] [Related]
9. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of full macular translocation for choroidal neovascularization.
Yamada Y; Miyamura N; Suzuma K; Kitaoka T
Am J Ophthalmol; 2010 Mar; 149(3):453-7.e1. PubMed ID: 20035923
[TBL] [Abstract][Full Text] [Related]
11. [Intravitreal injection of rt-PA and gas in the management of minor submacular haemorrhages secondary to age-related macular degeneration].
Hattenbach LO; Brieden M; Koch F; Gümbel H
Klin Monbl Augenheilkd; 2002 Jul; 219(7):512-8. PubMed ID: 12195317
[TBL] [Abstract][Full Text] [Related]
12. Full macular translocation following photodynamic therapy in neovascular age-related macular degeneration.
Suesskind D; Voelker M; Bartz-Schmidt KU; Gelisken F
Eye (Lond); 2008 Jun; 22(6):834-7. PubMed ID: 17401325
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of ranibizumab for neovascular age-related macular degeneration using clinician-determined retreatment strategy.
Kumar A; Sahni JN; Stangos AN; Campa C; Harding SP
Br J Ophthalmol; 2011 Apr; 95(4):530-3. PubMed ID: 20937739
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.
Furino C; Boscia F; Recchimurzo N; Besozzi G; Cardascia N; Sborgia L; Niro A; Sborgia C
Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335
[TBL] [Abstract][Full Text] [Related]
15. [Retina transplantation in exudative form of age-related macular degeneration].
Figurska M; Stankiewicz A
Klin Oczna; 2002; 104(2):143-6. PubMed ID: 12174458
[TBL] [Abstract][Full Text] [Related]
16. A comparison of macular translocation with patch graft in neovascular age-related macular degeneration.
Chen FK; Patel PJ; Uppal GS; Rubin GS; Coffey PJ; Aylward GW; Da Cruz L
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1848-55. PubMed ID: 19060287
[TBL] [Abstract][Full Text] [Related]
17. Macular translocation with chorioscleral outfolding: 2-year results.
Kamei M; Tano Y; Yasuhara T; Ohji M; Lewis H
Am J Ophthalmol; 2004 Oct; 138(4):574-81. PubMed ID: 15488783
[TBL] [Abstract][Full Text] [Related]
18. One-year results of a flexible regimen with ranibizumab therapy in macular degeneration: relationship with the number of injections.
Arias L; Roman I; Masuet-Aumatell C; Rubio MJ; Caminal JM; Catala J; Pujol O
Retina; 2011; 31(7):1261-7. PubMed ID: 21499194
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal ranibizumab for myopic choroidal neovascularization: factors predictive of visual outcome and need for retreatment.
Calvo-Gonzalez C; Reche-Frutos J; Donate J; Fernandez-Perez C; Garcia-Feijoo J
Am J Ophthalmol; 2011 Mar; 151(3):529-34. PubMed ID: 21236413
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal ranibizumab versus thermal laser photocoagulation in the treatment of extrafoveal classic choroidal neovascularization secondary to age-related macular degeneration.
Ladas ID; Chatziralli IP; Kotsolis AI; Douvali M; Georgalas I; Theodossiadis PG; Rouvas AA
Ophthalmologica; 2012; 228(2):93-101. PubMed ID: 22571933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
